Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
37.17
+0.26 (0.69%)
At close: Jun 6, 2025, 4:00 PM
37.61
+0.45 (1.20%)
After-hours: Jun 6, 2025, 5:10 PM EDT

Ultragenyx Pharmaceutical Market Cap

Ultragenyx Pharmaceutical has a market cap or net worth of $3.51 billion as of June 6, 2025. Its market cap has increased by 1.60% in one year.

Market Cap
3.51B
Enterprise Value
3.83B
1-Year Change
1.60%
Ranking
Category
Stock Price
$37.17

Market Cap Chart

Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.51B, an increase of 195.03%. That is a compound annual growth rate of 10.00%.

History

DateMarket Cap% Change
Jun 5, 20253.49B-10.18%
Dec 31, 20243.88B-1.06%
Dec 29, 20233.93B20.90%
Dec 30, 20223.25B-43.33%
Dec 31, 20215.73B-32.17%
Dec 31, 20208.45B242.48%
Dec 31, 20192.47B12.20%
Dec 31, 20182.20B11.33%
Dec 29, 20171.98B-31.24%
Dec 30, 20162.87B-34.05%
Dec 31, 20154.36B211.25%
Dec 31, 20141.40B17.73%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 690.92B
Johnson & Johnson 372.41B
AbbVie 336.01B
Novo Nordisk 324.15B
UnitedHealth Group 271.92B
Abbott Laboratories 232.65B
Novartis AG 230.96B
AstraZeneca 225.55B
Market Cap Rankings